NO20013103D0 - Aciclovirsammensetninger inneholdende dimeticon - Google Patents

Aciclovirsammensetninger inneholdende dimeticon

Info

Publication number
NO20013103D0
NO20013103D0 NO20013103A NO20013103A NO20013103D0 NO 20013103 D0 NO20013103 D0 NO 20013103D0 NO 20013103 A NO20013103 A NO 20013103A NO 20013103 A NO20013103 A NO 20013103A NO 20013103 D0 NO20013103 D0 NO 20013103D0
Authority
NO
Norway
Prior art keywords
aciclovir
compositions containing
dimeticone
containing dimeticone
compositions
Prior art date
Application number
NO20013103A
Other languages
English (en)
Other versions
NO322090B1 (no
NO20013103L (no
Inventor
Parbinder Singh Cheema
Andrew David Mounter
Timothy Giles Sabey
David Gower
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10845017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20013103(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20013103D0 publication Critical patent/NO20013103D0/no
Publication of NO20013103L publication Critical patent/NO20013103L/no
Publication of NO322090B1 publication Critical patent/NO322090B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20013103A 1998-12-23 2001-06-21 Topisk farmasoytisk formulering inneholdende dimeticon, samt fremstilling derav NO322090B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9828620.6A GB9828620D0 (en) 1998-12-23 1998-12-23 Medicaments
PCT/EP1999/010155 WO2000038695A2 (en) 1998-12-23 1999-12-21 Aciclovir compositions containing dimethicone

Publications (3)

Publication Number Publication Date
NO20013103D0 true NO20013103D0 (no) 2001-06-21
NO20013103L NO20013103L (no) 2001-08-20
NO322090B1 NO322090B1 (no) 2006-08-14

Family

ID=10845017

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013103A NO322090B1 (no) 1998-12-23 2001-06-21 Topisk farmasoytisk formulering inneholdende dimeticon, samt fremstilling derav

Country Status (27)

Country Link
EP (1) EP1140117B1 (no)
JP (1) JP4145493B2 (no)
KR (1) KR100707329B1 (no)
CN (2) CN100415237C (no)
AR (1) AR021993A1 (no)
AT (1) ATE236644T1 (no)
AU (1) AU768989B2 (no)
BR (1) BR9916524A (no)
CA (1) CA2356895A1 (no)
CZ (1) CZ295770B6 (no)
DE (2) DE69906796T2 (no)
DK (1) DK1140117T3 (no)
ES (1) ES2196910T3 (no)
GB (2) GB9828620D0 (no)
HK (2) HK1039275A1 (no)
HU (1) HU230542B1 (no)
IL (2) IL143833A0 (no)
NO (1) NO322090B1 (no)
NZ (1) NZ512457A (no)
PE (1) PE20001351A1 (no)
PL (1) PL196629B1 (no)
PT (1) PT1140117E (no)
SI (1) SI1140117T1 (no)
TR (1) TR200102482T2 (no)
TW (1) TW585768B (no)
WO (1) WO2000038695A2 (no)
ZA (1) ZA200105071B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2005824A1 (de) † 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
WO2010046861A1 (en) * 2008-10-21 2010-04-29 Novodermix International Limited Composition for treatment of epithelial tissue
WO2012107575A1 (en) * 2011-02-10 2012-08-16 Moberg Derma Ab Novel formulations for dermal, transdermal and mucosal use 2
WO2015082172A1 (en) * 2013-12-03 2015-06-11 Zzip Ag Polydimethylsiloxane for the treatment of viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
AU5381590A (en) * 1989-04-24 1990-10-25 Syntex (U.S.A.) Inc. Topical antiviral pharmaceutical composition containing a nonionic surfactant
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
FR2728167A1 (fr) * 1994-12-15 1996-06-21 Cird Galderma Composition cosmetique ou dermatologique sous forme d'une emulsion eau dans huile a teneur elevee en hydroxyacides
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation

Also Published As

Publication number Publication date
HK1039275A1 (zh) 2002-04-19
GB9828620D0 (en) 1999-02-17
IL143833A (en) 2006-12-31
GB2362105A (en) 2001-11-14
ES2196910T3 (es) 2003-12-16
CN1334737A (zh) 2002-02-06
AR021993A1 (es) 2002-09-04
CN1539421A (zh) 2004-10-27
JP4145493B2 (ja) 2008-09-03
HUP0104594A3 (en) 2002-12-28
CN1191834C (zh) 2005-03-09
AU768989B2 (en) 2004-01-15
JP2002542149A (ja) 2002-12-10
CN100415237C (zh) 2008-09-03
NO322090B1 (no) 2006-08-14
NO20013103L (no) 2001-08-20
EP1140117B1 (en) 2003-04-09
DE69906796D1 (de) 2003-05-15
PE20001351A1 (es) 2000-12-14
KR20010099932A (ko) 2001-11-09
HU230542B1 (hu) 2016-11-28
WO2000038695A2 (en) 2000-07-06
GB0117795D0 (en) 2001-09-12
IL143833A0 (en) 2002-04-21
KR100707329B1 (ko) 2007-04-13
WO2000038695A3 (en) 2000-10-26
ZA200105071B (en) 2002-09-20
TR200102482T2 (tr) 2003-03-21
PL349505A1 (en) 2002-07-29
ATE236644T1 (de) 2003-04-15
EP1140117A2 (en) 2001-10-10
AU2099700A (en) 2000-07-31
DE69906796T2 (de) 2004-01-29
CA2356895A1 (en) 2000-07-06
PT1140117E (pt) 2003-08-29
DE29924428U1 (de) 2003-08-28
DK1140117T3 (da) 2003-07-21
CZ20012332A3 (cs) 2001-12-12
PL196629B1 (pl) 2008-01-31
TW585768B (en) 2004-05-01
HUP0104594A2 (en) 2002-06-29
HK1067548A1 (en) 2005-04-15
CZ295770B6 (cs) 2005-11-16
GB2362105B (en) 2003-06-18
BR9916524A (pt) 2001-10-02
SI1140117T1 (en) 2003-12-31
NZ512457A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
DE60033021D1 (de) Strukturierte kosmetische zusammensetzungen
DE69813601T2 (de) Stabile kosmetische zusammensetzungen
DE69815099T2 (de) Kosmetische zusammensetzungen
IS2325B (is) Örgerðar samsetningar epleróns
DE69900634T2 (de) Shampoozusammensetzungen
ATE283023T1 (de) Schäumende kosmetische zusammensetzungen
NO20005215D0 (no) Dihydropyrimidiner
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
DE69836106D1 (de) Stanolester enthaltende Zusammensetzungen
ID26549A (id) Komposisi-komposisi epotilon
ITMI991754A0 (it) Composizioni cosmetiche
ID22931A (id) Komposisi-komposisi herbisidal
ID28853A (id) Komposisi-komposisi antiperspiran
DE69929799D1 (de) Ultraviolettlicht absorbierende zusammensetzungen
DK0963291T3 (da) Forebyggelse af misfarvning i pyrithion-holdige coatingsammensætninger
DE69913233D1 (de) Kosmetische zusammensetzung
ATE367845T1 (de) Riechstoffzusammensetzungen
DE69931501D1 (de) Kosmetische zusammensetzung
DE69919953D1 (de) Funktionelle zusammensetzungen
ATE302589T1 (de) Kosmetische zusammensetzungen
DE69927758D1 (de) Imidosilan-Zusammensetzungen
DE69902473T2 (de) Kosmetikzusammensetzung
DE69838290D1 (de) Vernetzungszusammensetzungen
DE69809175D1 (de) Flavanon-enthaltende Zusammensetzungen
DE60037014D1 (de) Kosmetische zusammensetzungen enthaltend polysaccharid-sterol-derivate

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: GLAXO GROUP LTD, GB

MM1K Lapsed by not paying the annual fees